482 related articles for article (PubMed ID: 25747493)
1. Effects of (-)-sesamin on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and dopaminergic neuronal cells of Parkinson's disease rat models.
Park HJ; Zhao TT; Lee KS; Lee SH; Shin KS; Park KH; Choi HS; Lee MK
Neurochem Int; 2015; 83-84():19-27. PubMed ID: 25747493
[TBL] [Abstract][Full Text] [Related]
2. L-DOPA modulates cell viability through the ERK-c-Jun system in PC12 and dopaminergic neuronal cells.
Park KH; Shin KS; Zhao TT; Park HJ; Lee KE; Lee MK
Neuropharmacology; 2016 Feb; 101():87-97. PubMed ID: 26363191
[TBL] [Abstract][Full Text] [Related]
3. Repeated treatments with the D
Park HJ; Zhao TT; Park KH; Lee MK
Behav Brain Res; 2019 Jul; 367():166-175. PubMed ID: 30930179
[TBL] [Abstract][Full Text] [Related]
4. Effects of asarinin on dopamine biosynthesis and 6-hydroxydopamine-induced cytotoxicity in PC12 cells.
Park HJ; Lee KS; Zhao TT; Lee KE; Lee MK
Arch Pharm Res; 2017 May; 40(5):631-639. PubMed ID: 28397192
[TBL] [Abstract][Full Text] [Related]
5. Modulatory effects of sesamin on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells.
Zhang M; Lee HJ; Park KH; Park HJ; Choi HS; Lim SC; Lee MK
Neuropharmacology; 2012 Jun; 62(7):2219-26. PubMed ID: 22293035
[TBL] [Abstract][Full Text] [Related]
6. Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease.
Kwon IH; Choi HS; Shin KS; Lee BK; Lee CK; Hwang BY; Lim SC; Lee MK
Neurosci Lett; 2010 Dec; 486(1):29-33. PubMed ID: 20851167
[TBL] [Abstract][Full Text] [Related]
7. Effects of (-)-sesamin on motor and memory deficits in an MPTP-lesioned mouse model of Parkinson's disease treated with l-DOPA.
Zhao TT; Shin KS; Kim KS; Park HJ; Kim HJ; Lee KE; Lee MK
Neuroscience; 2016 Dec; 339():644-654. PubMed ID: 27789382
[TBL] [Abstract][Full Text] [Related]
8. The roles of cyclic AMP-ERK-Bad signaling pathways on 6-hydroxydopamine-induced cell survival and death in PC12 cells.
Park HJ; Park KH; Shin KS; Lee MK
Toxicol In Vitro; 2013 Dec; 27(8):2233-41. PubMed ID: 24055892
[TBL] [Abstract][Full Text] [Related]
9. Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Shin KS; Choi HS; Zhao TT; Suh KH; Kwon IH; Choi SO; Lee MK
Arch Pharm Res; 2013 Jun; 36(6):759-67. PubMed ID: 23539311
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C delta mediated cytotoxicity of 6-Hydroxydopamine via sustained extracellular signal-regulated kinase 1/2 activation in PC12 cells.
Fan Y; Li J; Zhang YQ; Jiang LH; Zhang YN; Yan CQ
Neurol Res; 2014 Jan; 36(1):53-64. PubMed ID: 24107416
[TBL] [Abstract][Full Text] [Related]
11. Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease.
Shim JS; Kim HG; Ju MS; Choi JG; Jeong SY; Oh MS
J Ethnopharmacol; 2009 Nov; 126(2):361-5. PubMed ID: 19703534
[TBL] [Abstract][Full Text] [Related]
12. Human albumin prevents 6-hydroxydopamine-induced loss of tyrosine hydroxylase in in vitro and in vivo.
Zhang LJ; Xue YQ; Yang C; Yang WH; Chen L; Zhang QJ; Qu TY; Huang S; Zhao LR; Wang XM; Duan WM
PLoS One; 2012; 7(7):e41226. PubMed ID: 22815976
[TBL] [Abstract][Full Text] [Related]
13. Modulation of PC12 cell viability by forskolin-induced cyclic AMP levels through ERK and JNK pathways: an implication for L-DOPA-induced cytotoxicity in nigrostriatal dopamine neurons.
Park KH; Park HJ; Shin KS; Choi HS; Kai M; Lee MK
Toxicol Sci; 2012 Jul; 128(1):247-57. PubMed ID: 22539619
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
15. Sesamin imparts neuroprotection against intrastriatal 6-hydroxydopamine toxicity by inhibition of astroglial activation, apoptosis, and oxidative stress.
Baluchnejadmojarad T; Mansouri M; Ghalami J; Mokhtari Z; Roghani M
Biomed Pharmacother; 2017 Apr; 88():754-761. PubMed ID: 28157651
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Protective Role of Multifunctional Dopamine Agonist D-512 Against Oxidative Stress Produced by Depletion of Glutathione in PC12 Cells: Implication in Neuroprotective Therapy for Parkinson's Disease.
Voshavar C; Shah M; Xu L; Dutta AK
Neurotox Res; 2015 Nov; 28(4):302-18. PubMed ID: 26201265
[TBL] [Abstract][Full Text] [Related]
17. FGF18 protects against 6-hydroxydopamine-induced nigrostriatal damage in a rat model of Parkinson's disease.
Guo X; Liu T; Zhao D; Wang X; Liu D; He Y; Shan C; Kong Y; Hu W; Tao B; Sun L; Zhao H; Li S; Liu J
Neuroscience; 2017 Jul; 356():229-241. PubMed ID: 28504195
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of sesamin and sesamolin on hypoxic neuronal and PC12 cells.
Hou RC; Huang HM; Tzen JT; Jeng KC
J Neurosci Res; 2003 Oct; 74(1):123-33. PubMed ID: 13130514
[TBL] [Abstract][Full Text] [Related]
19. Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine.
Rodriguez-Blanco J; Martín V; Herrera F; García-Santos G; Antolín I; Rodriguez C
J Neurochem; 2008 Oct; 107(1):127-40. PubMed ID: 18665912
[TBL] [Abstract][Full Text] [Related]
20. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
Francardo V; Recchia A; Popovic N; Andersson D; Nissbrandt H; Cenci MA
Neurobiol Dis; 2011 Jun; 42(3):327-40. PubMed ID: 21310234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
